Ignite Creation Date:
2025-12-24 @ 4:49 PM
Ignite Modification Date:
2026-01-25 @ 8:52 AM
Study NCT ID:
NCT00840450
Status:
TERMINATED
Last Update Posted:
2012-11-19
First Post:
2009-02-09
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Imatinib Mesylate (Gleevec) and Paclitaxel in Recurrent Patients of Ovarian and Other Cancers of Mullerian Origin
Sponsor:
NYU Langone Health
Organization: